US81663L2007
US81663L2007
GeneDx Holdings Corp.
Loading chart...
Company Profile
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Latest News

Simply Wall St. • 8h ago
Top 3 Healthcare Stocks To Watch In October 2026

Zacks • 10/08/2026
Teladoc Strengthens Solo Platform With New AI-Powered Care Tools

Zacks • 10/07/2026
Encompass Health Expands Rehab Footprint With New Maine Hospital

Business Wire • 10/07/2026
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026

Business Wire • 10/02/2026
GeneDx Introduces Easy Order at AAP 2026 to Simplify Genomic Testing in Everyday Pediatric Care
TIKR • 09/24/2026
GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?
Related stocks
Key Metrics & Overview
Detailed metrics & financial data of the company
Company Profile
5
MetricsCountry
Region
Sector
Industry
Website
🛡️ Risk & Structural Analysis
Multi-Factor Risk Model & Market Data
7/7 Very High
5Y Volatility
109.8% p.a.
Max Drawdown (5Y)
-99.6%
Sharpe Ratio (5Y)
-0.24
Beta Factor
1.97
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
High market risk: Beta of 1.97 indicates above-average volatility compared to the broader market.
🔴 High valuation risk: Avg P/E of 56.2 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (109.8% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -99.6% in the extended horizon.